These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 39256495)
21. Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease. Asadi M; Ebrahimi M; Mohammadi-Khanaposhtani M; Azizian H; Sepehri S; Nadri H; Biglar M; Amanlou M; Larijani B; Mirzazadeh R; Edraki N; Mahdavi M Chem Biodivers; 2019 Nov; 16(11):e1900370. PubMed ID: 31523926 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459 [TBL] [Abstract][Full Text] [Related]
23. Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease. Rosales Hernández MC; Olvera-Valdez M; Velazquez Toledano J; Mendieta Wejebe JE; Fragoso Morales LG; Cruz A Molecules; 2024 Oct; 29(19):. PubMed ID: 39407708 [TBL] [Abstract][Full Text] [Related]
24. A Series of Novel 1- Krzyżak E; Marciniak A; Szkatuła D; Jankowska KA; Dobies N; Kotynia A Molecules; 2024 Jul; 29(15):. PubMed ID: 39124935 [TBL] [Abstract][Full Text] [Related]
25. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands]. Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754 [TBL] [Abstract][Full Text] [Related]
26. From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold. Rampa A; Mancini F; De Simone A; Falchi F; Belluti F; Di Martino RM; Gobbi S; Andrisano V; Tarozzi A; Bartolini M; Cavalli A; Bisi A Bioorg Med Chem Lett; 2015 Jul; 25(14):2804-8. PubMed ID: 26003339 [TBL] [Abstract][Full Text] [Related]
27. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease. Saeedi M; Rastegari A; Hariri R; Mirfazli SS; Mahdavi M; Edraki N; Firuzi O; Akbarzadeh T Chem Biodivers; 2020 May; 17(5):e1900746. PubMed ID: 32154628 [TBL] [Abstract][Full Text] [Related]
28. Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors. Bhakta HK; Park CH; Yokozawa T; Min BS; Jung HA; Choi JS Arch Pharm Res; 2016 Jun; 39(6):794-805. PubMed ID: 27106028 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease. Rastegari A; Safavi M; Vafadarnejad F; Najafi Z; Hariri R; Bukhari SNA; Iraji A; Edraki N; Firuzi O; Saeedi M; Mahdavi M; Akbarzadeh T Mol Divers; 2022 Feb; 26(1):409-428. PubMed ID: 34273065 [TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological evaluation, molecular docking, and MD simulation of novel 2,4-disubstituted quinazoline derivatives as selective butyrylcholinesterase inhibitors and antioxidant agents. Sadeghian S; Razmi R; Khabnadideh S; Khoshneviszadeh M; Mardaneh P; Talashan A; Pirouti A; Khebre F; Zahmatkesh Z; Rezaei Z Sci Rep; 2024 Jul; 14(1):15577. PubMed ID: 38971857 [TBL] [Abstract][Full Text] [Related]
32. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents. Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824 [TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors. Gabr MT; Abdel-Raziq MS Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870 [TBL] [Abstract][Full Text] [Related]
34. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease. Manral A; Saini V; Meena P; Tiwari M Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of bakuchiol derivatives as multi-target agents for the treatment of Alzheimer's disease. Zhang XQ; Xiang YN; Qin T; Zou JP; Guo QW; Han ST; Zhang ZY; Liu WW; Ding G; Dong JQ; Shi DH Fitoterapia; 2024 Apr; 174():105867. PubMed ID: 38382891 [TBL] [Abstract][Full Text] [Related]
36. Identification of ovalbumin-derived peptides as multi-target inhibitors of AChE, BChE, and BACE1. Yu Z; Dong W; Wu S; Shen J; Zhao W; Ding L; Liu J; Zheng F J Sci Food Agric; 2020 Apr; 100(6):2648-2655. PubMed ID: 31997357 [TBL] [Abstract][Full Text] [Related]
37. New Benzamides as Multi-Targeted Compounds: A Study on Synthesis, AChE and BACE1 Inhibitory Activity and Molecular Docking. Drozdowska D; Maliszewski D; Wróbel A; Ratkiewicz A; Sienkiewicz M Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834347 [TBL] [Abstract][Full Text] [Related]
38. Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's. Sun ZQ; Tu LX; Zhuo FJ; Liu SX Bioorg Med Chem Lett; 2016 Feb; 26(3):747-750. PubMed ID: 26783181 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115 [TBL] [Abstract][Full Text] [Related]
40. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation. Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]